Clinical trial
Prospective Study Incorporating LUMENEYE Rectoscope for Assessment on Tumor Response After Total Neoadjuvant Treatment in Rectal Cancer
NCT06189846 is registered in ClinicalTrials.gov with Bordeaux Colorectal Institute Academy as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Prospective Study Incorporating LUMENEYE Rectoscope for Assessment on Tumor Response After Total Neoadjuvant Treatment in Rectal Cancer
- Lead sponsor
- Bordeaux Colorectal Institute Academy
- Phase
- Observational
- Overall status
- Completed
- Start date
- January 4, 2024
- Completion date
- March 5, 2026
- Enrollment
- 82 (actual)
- Sites
- 8
Conditions
As the registry lists them; a condition with its own page is linked.
rectal cancer